Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000106

Senior Vice President, Finance sold 9,999 shares at an average $80.60 ($805,889)

  • Senior Vice President, Finance acquired 9,999 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Agarwal Arjun Senior Vice President, Finance 2026-10-12 Option exercise 10b5-1 +8,541 $12.50 $106,763 22,760 D
Agarwal Arjun Senior Vice President, Finance 2026-10-12 Option exercise 10b5-1 +1,458 $34.39 $50,141 24,218 D
Agarwal Arjun Senior Vice President, Finance 2026-10-12 Sale 10b5-1 −5,741 $80.03 $459,453 18,477 D
Agarwal Arjun Senior Vice President, Finance 2026-10-12 Sale 10b5-1 −2,100 $80.76 $169,596 16,377 D
Agarwal Arjun Senior Vice President, Finance 2026-10-12 Sale 10b5-1 −1,958 $81.86 $160,272 14,419 D
Agarwal Arjun Senior Vice President, Finance 2026-10-12 Sale 10b5-1 −200 $82.84 $16,567 14,219 D
Derivatives
Agarwal Arjun Senior Vice President, Finance 2026-10-12 Option exercise · Employee Stock Option (right to buy) 10b5-1 −8,541 76,376 D
Agarwal Arjun Senior Vice President, Finance 2026-10-12 Option exercise · Employee Stock Option (right to buy) 10b5-1 −1,458 56,875 D
Open-market sales · 9,999 sh · avg $80.60 · $805,889
Loading xslF345X06/form4.xml…